Biomea Fusion (BMEA.US) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Dec26

Biomea Fusion Expects to Complete Key Clinical Trial Milestones by End of Q4 2025

01:21

Dec25

Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference

18:51

Dec23

Biomea Fusion Expected to Announce Clinical Trial Progress in the First Half of 2026

22:12

Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference

18:41

Dec21

Biomea Fusion expects to initiate its Phase II trial for GLP-1 drug COVALENT-212 in Q1 2026

16:30

Dec20

Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference

13:50

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -16.41 M, EPS -0.2741

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -20.74 M, EPS -0.5104

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -29.26 M, EPS -0.7989

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change